Fisher Asset Management
RXII

Fisher Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Fisher Asset Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,329
Closed -$4K – 762
2016
Q3 		$4K Hold
11,329
– – ﹤0.01% 727
2016
Q2 		$5K Hold
11,329
– – ﹤0.01% 696
2016
Q1 		$17K Hold
11,329
– – ﹤0.01% 687
2015
Q4 		$17K Sell
11,329
-5,000
-31% -$7.5K ﹤0.01% 735
2015
Q3 		$26K Buy
+16,329
New +$26K ﹤0.01% 662

Fisher Asset Management's RXII Position: Q4 2016 in Review

Fisher Asset Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 11,329 shares — an estimated $4K sold.

Fisher Asset Management first reported a position in RXII in Q3 2015 and held it in 5 quarters. The position peaked at $26K in Q3 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Fisher Asset Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Fisher Asset Management sold 11,329 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Fisher Asset Management first reported a position in GALENA BIOPHARMA INC COM in Q3 2015 and held it in 5 quarters.
  • Fisher Asset Management's GALENA BIOPHARMA INC COM position peaked at $26K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Fisher Asset Management's 13F filing for Q4 2016, filed 10 Jan 2017.